• Rafal Berger, Attila Nemeth, Christoph Salewski, Rodrigo Sandoval Boburg, Metesh Acharya, Alexander Weymann, Konstantin Zhigalov, Bastian Schmack, Sá Michel Pompeu B O MPBO 0000-0001-5356-2996 Department of Cardiovascular Surgery at the Pronto Socorro Cardiológico de Pernambuco (PROCAPE), 74970-2, Christian Schlensak, and Aron-Frederik Popov.
• Department of Thoracic and Cardiovascular Surgery, University Hospital of Tübingen, 72070 Tübingen, Germany.
• Medicina (Kaunas). 2020 Aug 23; 56 (9).

AbstractBackground and Objectives: Since the first use of ventricular assist devices (VADs) as bridge to recovery and bridge to cardiac transplantation in the early 1990s, significant technological advances have transformed VAD implantation into a routine destination therapy. With improved survival, many patients present for cardiac surgery for conditions not directly related to their permanent mechanical circulatory support. The aim of this study was to analyze the indications and outcomes of non-cardiac surgeries (NCSs) of left ventricular assist device (LVAD) patients in tertiary center. Material and Methods: We present a single-center experience after 151 LVAD implantations in 138 consecutive patients between 2012-2019 who had to undergo NCS during a follow-up period of 37 +/- 23.4 months on left ventricular assist device (LVAD). Results: A total of 105 procedures was performed in 63 LVAD recipients, resulting in peri-operative mortality of 3.8%. Twenty-five (39.7%) of patients underwent multiple surgeries. We found no significant difference in cumulative survival associated with the performed surgical interventions (p = 0.469). Conclusion: We demonstrated good overall clinical outcomes in LVAD patients undergoing NCS. With acceptable peri-operative mortality, NCS can be safely performed in LVAD patients on long-term support.

22 keywords...

hide…